Shurong graduated from the University of Michigan for her PhD in Pharmaceutical Science, with research focus on nucleic acid therapeutics delivery for cancer immunotherapeutics. She joins the Simon Lab to work on the development and application of advanced CAR-T therapies, with a focus on novel gene delivery modalities.